| Trial ID: | L4037 |
| Source ID: | NCT00259896
|
| Associated Drug: |
Exenatide
|
| Title: |
In-patient Study in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: exenatide
|
| Outcome Measures: |
Primary: Pharmacodynamic measurements during 7 days of dosing. | Secondary: Pharmacokinetic measurements during 7 days of dosing.
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-10
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-04
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00259896
|
